Agilus Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 97.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 78.43 Cr
as on 16-11-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 71.33 Cr
as on 16-11-2024
- Satisfied Charges ₹ 284.24 Cr
as on 16-11-2024
- Revenue -12.76%
(FY 2023)
- Profit -48.64%
(FY 2023)
- Ebitda -49.04%
(FY 2023)
- Net Worth 3.31%
(FY 2023)
- Total Assets 3.73%
(FY 2023)
About Agilus Diagnostics
The Corporate was formerly known as Srl Ranbaxy Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 97.00 Cr and a paid-up capital of Rs 78.43 Cr.
The company currently has active open charges totaling ₹71.33 Cr. The company has closed loans amounting to ₹284.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Agilus Diagnostics Limited India are Akshay Tiwari as Cfo, Trapti Kushwaha as Company Secretary, and Anand Kuppuswamy as Ceo. Suvalaxmi Chakraborty, Indrajit Banerjee, Dilip Kadambi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74899PB1995PLC045956
- Company No.
045956
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1995
- Date of AGM
01 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Agilus Diagnostics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Kuppuswamy  | Managing Director | 04-Aug-2023 | Current |
| Akshay Tiwari | CFO | 07-Oct-2024 | Current |
| Trapti Kushwaha | Company Secretary | 25-Sep-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suvalaxmi Chakraborty | Director | 23-Jun-2018 | Current |
| Indrajit Banerjee | Additional Director | 15-Nov-2024 | Current |
| Dilip Kadambi | Director | 06-Apr-2021 | Current |
| Ashutosh Raghuvanshi | Director | 20-Mar-2019 | Current |
| Ashok Pandit | Director | 15-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Agilus Diagnostics.
Agilus Diagnostics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.76% decrease. The company also saw a substantial fall in profitability, with a 48.64% decrease in profit. The company's net worth moved up by a moderate rise of 3.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agilus Diagnostics?
In 2023, Agilus Diagnostics had a promoter holding of 57.68% and a public holding of 42.32%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fortis Healthcare LimitedActive 28 years 9 monthsSuvalaxmi Chakraborty, Indrajit Banerjee and 3 more are mutual person
- Fortis Hospotel LimitedActive 34 years 10 months
Indrajit Banerjee and Ashutosh Raghuvanshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2024 | ₹1.96 M | Open |
Others Creation Date: 27 Jul 2023 | ₹4.14 M | Open |
Others Creation Date: 20 Jul 2023 | ₹2.62 M | Open |
How Many Employees Work at Agilus Diagnostics?
Agilus Diagnostics has a workforce of 3385 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agilus Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agilus Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
